Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A clinician-reviewed guide to delayed-onset and rare adverse effects of rosuvastatin (Crestor), including myopathy timelines, new-onset diabetes risk, proteinuria, and cognitive reports. Backed by FDA label data, FAERS analysis, and landmark statin trials.
Read clinical reviewA physician-reviewed breakdown of rosuvastatin (Crestor) adverse events by severity grade, dose, and patient phenotype, including myopathy risk, hepatic effects, and diabetes signal, with data from JUPITER, FAERS, and the FDA prescribing label.
Read clinical reviewA data-driven breakdown of rosuvastatin (Crestor) adverse event rates drawn from JUPITER, METEOR, CORONA, post-market FAERS data, and the FDA prescribing label, with real trial numbers and clinical context.
Read clinical reviewA clinically detailed guide to the rare but serious adverse events linked to Crestor (rosuvastatin), including myopathy, rhabdomyolysis, liver injury, new-onset diabetes, and interstitial lung disease, with trial data, FDA label citations, and dosing guidance.
Read clinical reviewDoes stopping rosuvastatin (Crestor) cause withdrawal symptoms? Learn what the evidence says about discontinuation syndrome, rebound effects, muscle pain, and how to safely taper or stop statins.
Read clinical review